Literature DB >> 25192422

Effect of dietary lipids on circulating adiponectin: a systematic review with meta-analysis of randomised controlled trials.

Anize D von Frankenberg1, Flávia M Silva1, Jussara C de Almeida1, Vanessa Piccoli1, Filipe V do Nascimento1, Mônica M Sost1, Cristiane B Leitão1, Luciana L R Remonti1, Daniel Umpierre2, André F Reis3, Luis H Canani1, Mirela J de Azevedo1, Fernando Gerchman1.   

Abstract

Different dietary interventions have been identified as potential modifiers of adiponectin concentrations, and they may be influenced by lipid intake. We identified studies investigating the effect of dietary lipids (type/amount) on adiponectin concentrations in a systematic review with meta-analysis. A literature search was conducted until July 2013 using databases such as Medline, Embase and Scopus (MeSH terms: 'adiponectin', 'dietary lipid', 'randomized controlled trials (RCT)'). Inclusion criteria were RCT in adults analysing adiponectin concentrations with modification of dietary lipids. Among the 4930 studies retrieved, fifty-three fulfilled the inclusion criteria and were grouped as follows: (1) total dietary lipid intake; (2) dietary/supplementary n-3 PUFA; (3) conjugated linoleic acid (CLA) supplementation; (4) other dietary lipid interventions. Diets with a low fat content in comparison to diets with a high-fat content were not associated with positive changes in adiponectin concentrations (twelve studies; pooled estimate of the difference in means: -0·04 (95% CI -0·82, 0·74) μg/ml). A modest increase in adiponectin concentrations with n-3 PUFA supplementation was observed (thirteen studies; 0·27 (95% CI 0·07, 0·47) μg/ml). Publication bias was found by using Egger's test (P= 0·01) and funnel plot asymmetry. In contrast, CLA supplementation reduced the circulating concentrations of adiponectin compared with unsaturated fat supplementation (seven studies; -0·74 (95% CI -1·38, -0·10) μg/ml). However, important sources of heterogeneity were found as revealed by the meta-regression analyses of both n-3 PUFA and CLA supplementation. Results of new RCT would be necessary to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25192422     DOI: 10.1017/S0007114514002013

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  14 in total

1.  Adverse effects of honey on low-density lipoprotein cholesterol and adiponectin concentrations in patients with type 2 diabetes: a randomized controlled cross-over trial.

Authors:  Fatemeh Sadeghi; Masoumeh Akhlaghi; Saedeh Salehi
Journal:  J Diabetes Metab Disord       Date:  2020-04-14

Review 2.  Pathophysiology of Non Alcoholic Fatty Liver Disease.

Authors:  Salvatore Petta; Amalia Gastaldelli; Eleni Rebelos; Elisabetta Bugianesi; Piergiorgio Messa; Luca Miele; Gianluca Svegliati-Baroni; Luca Valenti; Ferruccio Bonino
Journal:  Int J Mol Sci       Date:  2016-12-11       Impact factor: 5.923

3.  DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPARγ and its phosphorylation at Ser273 in 3T3-L1 adipocytes.

Authors:  Jia Song; Cheng Li; Yushan Lv; Yi Zhang; William Kwame Amakye; Limei Mao
Journal:  Nutr Metab (Lond)       Date:  2017-08-11       Impact factor: 4.169

Review 4.  Integrated Immunomodulatory Mechanisms through which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction.

Authors:  Danyelle M Liddle; Amber L Hutchinson; Hannah R Wellings; Krista A Power; Lindsay E Robinson; Jennifer M Monk
Journal:  Nutrients       Date:  2017-11-27       Impact factor: 5.717

5.  Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study.

Authors:  Ângela Cristine Bersch-Ferreira; Geni Rodrigues Sampaio; Marcella Omena Gehringer; Elizabeth Aparecida Ferraz da Silva Torres; Maria Beatriz Ross-Fernandes; Jacqueline Tereza da Silva; Camila Ragne Torreglosa; Cristiane Kovacs; Renata Alves; Carlos Daniel Magnoni; Bernardete Weber; Marcelo Macedo Rogero
Journal:  Nutr J       Date:  2018-02-21       Impact factor: 3.271

6.  Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients.

Authors:  M Gorety Jacobo-Cejudo; Roxana Valdés-Ramos; Ana L Guadarrama-López; Rosa-Virgen Pardo-Morales; Beatriz E Martínez-Carrillo; Laurence S Harbige
Journal:  Nutrients       Date:  2017-06-03       Impact factor: 5.717

7.  Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial.

Authors:  Aoibheann M McMorrow; Ruth M Connaughton; Tiago R Magalhães; Fiona C McGillicuddy; Maria F Hughes; David Cheishvili; Melissa J Morine; Sean Ennis; Marie-Louise Healy; Edna F Roche; Richard E Tremblay; Moshe Szyf; Fiona E Lithander; Helen M Roche
Journal:  Mol Nutr Food Res       Date:  2018-05       Impact factor: 5.914

8.  Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.

Authors:  Yu Qin; Yong Zhou; Shi-Hui Chen; Xiao-Lan Zhao; Li Ran; Xiang-Long Zeng; Ying Wu; Jun-Li Chen; Chao Kang; Fu-Rong Shu; Qian-Yong Zhang; Man-Tian Mi
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

9.  Fasting and postprandial regulation of the intracellular localization of adiponectin and of adipokines secretion by dietary fat in rats.

Authors:  V Olivares-García; I Torre-Villalvazo; L Velázquez-Villegas; G Alemán; N Lara; P López-Romero; N Torres; A R Tovar; A Díaz-Villaseñor
Journal:  Nutr Diabetes       Date:  2015-11-30       Impact factor: 5.097

10.  Fish Oil-Derived Long-Chain n-3 Polyunsaturated Fatty Acids Reduce Expression of M1-Associated Macrophage Markers in an ex vivo Adipose Tissue Culture Model, in Part through Adiponectin.

Authors:  Anna A De Boer; Jennifer M Monk; Danyelle M Liddle; Krista A Power; David W L Ma; Lindsay E Robinson
Journal:  Front Nutr       Date:  2015-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.